PATENT CLAIM ANALYSIS

Application Number: 15981598
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["435", "060000"]

Abstract:
The present application relates to novel substituted 5-fluoro-1H-pyrazolopyridines, to processes for their preparation, to their use alone or in combinations for the treatment and/or prophylaxis of diseases, and to their use for producing medicaments for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular disorders.

Claim (Index 60):
A method of treating or preventing one or more of hypertension, pulmonary hypertension, heart failure, coronary heart disease, systolic or diastolic heart failure, angina pectoris, ischaemias, peripheral and cardiac vascular disorders, kidney failure, renal insufficiency, and increased microalbuminurea, comprising administering to a human or animal in need thereof therapeutically effective amounts of\n (1) a compound of formula (I-A) or a salt thereof; and (2) a further active compound selected from the group consisting of organic nitrates, NO donors, cGMP-PDE inhibitors, agents having antithrombotic activity, agents lowering blood pressure, and agents altering lipid metabolism.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.80645
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15348545', '13111856', '14552122', '14194224', '13882118']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6090370757271953
- 35 USC 102 Novelty (BERT): 0.5587189326964995
- Combined Prediction Score: 0.6040052614241257
- Mean Citation Score: 380.31979400000006
- Max Citation Score: 433.06305
- Similarity Product: 358.38659018972214

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test